You'll learn how GLP-1 agonists (semaglutide, tirzepatide) produce dramatic results, how fat-burning peptides (AOD 9604) work differently, which peptides preserve muscle during weight loss, and how to build complete protocols for your specific situation
Glucagon-Like Peptide 1 Receptor Agonists and Pathways Underlying Coronary Events Glucagon-Like Peptide 1 Receptor Agonists and Atherosclerosis of Epicardial Coronary Arteries Atherosclerosis is a chronic condition that can progressively occlude epicardial coronary arteries
This meal plan gives you the "what to eat." For the complete story on "why it works," side effect management strategies, and protein preservation science, read our Ultimate Guide to the GLP-1 Diet
2020 Jul;37(7):120
Accordingly, VSMC dysfunction ultimately aggravates vascular injury and accelerates the development of atherosclerosis
Patients who severely under-eat during semaglutide therapy may experience dizziness, weakness, difficulty climbing stairs, and delayed recovery from minor illnesses